Note that locoregional IL-15 delivery in PNP-1-5 hydrogels coupled with intravenous administration of “mock” CAR-T cells has no effect on tumor growth, confirming that CAR functionality is necessary for treatment and that the locoregional exposure of IL-15 at this dose is insufficient to produce antitumor responses. Here, IL15 is linked to neoplasm.